Doug Wilson

Doug Wilson

Teknisk/Vetenskaplig/F&U Direktör på
Ferghana Partners Group
89 år
Health Technology
Finance
Consumer Non-Durables

Profil

Douglas John Wilson is currently the Director at Vaxxit SRL, Mainz Consulting Ltd., and the Chief Medical Officer at Ferghana Partners Group.
He previously served as Chairman at SeaDragon Ltd. from 2012 to 2015, Chairman at Adherium (NZ) Ltd., Non-Executive Chairman at Adherium Ltd., and Non-Independent Executive Director at Neuren Pharmaceuticals Ltd. from 2011 to 2012.
He also served as Non-Executive Director at PYC Therapeutics Ltd. from 2007 to 2016 and as Independent Non-Executive Director at Photonz Corp.
Ltd. from 2011 to 2013.
Additionally, he is currently serving as an Independent Non-Executive Director at AFT Pharmaceuticals Ltd. since 2012.
He previously worked as Senior Vice President-Medical & Regulatory Affairs at Boehringer Ingelheim Pharmaceuticals, Inc. He holds a doctorate degree from the University of London.

Aktiva positioner av Doug Wilson

FöretagPositionStart
Direktör/Styrelseledamot -
Mainz Consulting Ltd.
Direktör/Styrelseledamot -
Teknisk/Vetenskaplig/F&U Direktör -

Tidigare kända positioner av Doug Wilson

FöretagPositionSlut
AFT PHARMACEUTICALS LIMITED Direktör/Styrelseledamot 2022-08-05
PYC THERAPEUTICS LIMITED Ordförande 2015-10-08
SEADRAGON LIMITED Ordförande 2015-05-04
ADHERIUM LIMITED Ordförande 2016-09-01
Teknisk/Vetenskaplig/F&U Direktör -
Se detaljerna i Doug Wilsons erfarenhet

Doug Wilsons utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

27

Första gradens relationer

12

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag12

Health Technology

Finance

Consumer Non-Durables

Consumer Services

Health Technology

Health Technology

Technology Services

Health Technology

Health Technology

Health Technology

Health Technology

Mainz Consulting Ltd.

  1. Börsen
  2. Insiders
  3. Doug Wilson
- 40% : De bästa verktygen för abonnenter som vill hitta morgondagens bästa investeringar!
d
:
:
TA FÖRDEL AV DET NU